Determinants for genome-wide epigenomics in metastatic breast cancer
转移性乳腺癌全基因组表观基因组学的决定因素
基本信息
- 批准号:8301480
- 负责人:
- 金额:$ 46.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-21 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedBindingBreast Cancer CellBreast CarcinomaCD4 Positive T LymphocytesCancer PatientCancerousCause of DeathCellsCessation of lifeCharacteristicsChromatinChromosomesCytokine GeneDNADNA PackagingDNA SequenceDataDisease ProgressionDisseminated Malignant NeoplasmDistantERBB2 geneEctopic ExpressionEpigenetic ProcessFutureGene ExpressionGene Expression ProfilingGene Expression RegulationGene MutationGene StructureGene TargetingGenesGenomeGrowthHelper-Inducer T-LymphocyteHigher Order Chromatin StructureHumanHuman GenomeIndividualMalignant NeoplasmsMapsModificationMolecular ProfilingMusMutationNeoplasm MetastasisNormal CellOrganPlayPrimary NeoplasmProteinsRecruitment ActivityReportingResearchRoleSeriesSolid NeoplasmStagingSubgroupT-LymphocyteTestingUnited StatesWomanbasecell typechromatin modificationchromatin remodelingepigenomicsgene functiongenome-widehistone modificationin vivoinsightmalignant breast neoplasmneoplastic celloutcome forecastresearch studysingle moleculethymocytetumortumor progression
项目摘要
Breast cancer is the most common cancer in women in the United States, causing ~40,000 deaths each year. In the proposed study, we will focus on breast cancer and determine what epigenomic changes cause breast cancer to acquire metastatic activity and how the changes are established. Epigenetic modifications of chromatin are associated with the expression status of individual genes. Here we propose a paradigm-shifting idea that a single molecule involved in global gene regulation underlies the massive epigenetic changes that drive the transformation of a tumor cell to aggressive metastastic tumor cells through binding to a subset of specialized DNA sequence that functions as chromosomal marks. We identified SATB1, a genome organizer in thymocytes, to be a key determinant in breast cancer metastasis by altering
expression of ~1000 genes, including many associated with poor prognosis. We will test a hypothesis that SATB1 causes progression of non-aggressive breast cancer to metastatic cancer by establishing genome-wide changes in epigenetic marks through global re-organization of higher-order chromatin structure. We further hypothesize that such re-organization involves SATB1 interaction with highly conserved, specialized DNA sequences called base unpairing regions (BURs), distributed throughout the human genome. These BURs may function as chromosome "marks" to which chromatin modifiers are recruited, thus resulting in specific epigenetic modifications throughout the genome characteristic of aggressive breast cancer. We will adopt a global mapping approach by high-throughput sequencing to map all putative BURs across the human genome and identify those that are bound by SATB1in aggressive breast cancer cells versus those in activated human T helper cells, a non cancerous cell-type where SATB1 is normally expressed. We will subsequently determine genome-wide histone modifications in SATB1-expressing metastatic cancer and SATB1-deficient, non-
aggressive breast cancer cells to determine whether aggressive cancer-associated changes in epigenetic marks are centered at SATB1-bound BURs. From the proposed research, we will define the role of BURs in establishing metastatic breast cancer-specific epigenetic marks through interaction with SATB1. These experiments will provide fundamental insight into disease progression that should be useful for developing future therapies.
乳腺癌是美国女性最常见的癌症,每年造成约40,000人死亡。在拟议的研究中,我们将专注于乳腺癌,并确定是什么表观基因组变化导致乳腺癌获得转移活性以及这些变化是如何建立的。染色质的表观遗传修饰与单个基因的表达状态有关。在这里,我们提出了一个范式转变的想法,一个单一的分子参与全球基因调控的基础上,大规模的表观遗传变化,驱动肿瘤细胞转化为侵略性肿瘤细胞通过结合到一个子集的专门的DNA序列,作为染色体标记的功能。我们通过改变胸腺细胞中的基因组组织者SATB 1,将其鉴定为乳腺癌转移的关键决定因素。
约1000个基因表达,包括许多与预后不良相关的基因。我们将通过高阶染色质结构的全局重组建立表观遗传标记的全基因组变化来检验SATB 1导致非侵袭性乳腺癌进展为转移性癌症的假设。我们进一步假设,这种重组涉及SATB 1相互作用的高度保守的,专门的DNA序列称为碱基不配对区(布尔斯),分布在整个人类基因组。这些布尔斯可以作为染色体“标记”,染色质修饰剂被募集到这些标记上,从而导致侵袭性乳腺癌特征性的整个基因组的特异性表观遗传修饰。我们将采用高通量测序的全球定位方法,在人类基因组中定位所有推定的布尔斯,并确定那些在侵袭性乳腺癌细胞中与SATB 1结合的BURs,以及那些在活化的人类T辅助细胞中与SATB 1结合的BURs,这是一种非癌细胞类型,SATB 1通常表达。我们随后将确定表达SATB 1的转移性癌症和SATB 1缺陷、非转移性癌症中的全基因组蛋白修饰。
侵袭性乳腺癌细胞,以确定表观遗传标记中侵袭性癌症相关变化是否集中在SATB 1结合的布尔斯。从拟议的研究中,我们将确定布尔斯的作用,在建立转移性乳腺癌特异性表观遗传标记,通过与SATB 1的相互作用。这些实验将提供对疾病进展的基本见解,这对开发未来的治疗方法是有用的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Terumi Kohwi-Shigematsu其他文献
Terumi Kohwi-Shigematsu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Terumi Kohwi-Shigematsu', 18)}}的其他基金
Genome organizer SATB1 function in salivary gland and development and growth
基因组组织者 SATB1 在唾液腺及其发育和生长中的功能
- 批准号:
10593721 - 财政年份:2023
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
9244030 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
8675078 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
8865636 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
9213517 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
9484083 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
Benzo[a]pyrene-induced chromatin organization and epigenomics mediated by SATB1
SATB1介导的苯并[a]芘诱导的染色质组织和表观基因组学
- 批准号:
9043728 - 财政年份:2014
- 资助金额:
$ 46.78万 - 项目类别:
CHARACTERIZATION OF SATB1 MODIFICATIONS FOLLOWING IONIZATION RADIATION
电离辐射后 SATB1 修饰的表征
- 批准号:
8170703 - 财政年份:2010
- 资助金额:
$ 46.78万 - 项目类别:
Determinants for genome-wide epigenomics in metastatic breast cancer
转移性乳腺癌全基因组表观基因组学的决定因素
- 批准号:
7726410 - 财政年份:2009
- 资助金额:
$ 46.78万 - 项目类别:
Non B DNA Structure with Chemical Carcinogens
含有化学致癌物质的非 B DNA 结构
- 批准号:
7909158 - 财政年份:2009
- 资助金额:
$ 46.78万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 46.78万 - 项目类别:
Discovery Projects